Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection

Mullins, Christopher; Eisen, Geoffrey; Popper, Stephen; Dieng Sarr, Abdoulaye; Sankalé, Jean-Louis; Berger, Judith J.; Wright, Sharon B.; Chang, Hernan R.; Coste, Gérard; Cooley, Timothy P.; Rice, Peter; Skolnik, Paul R.; Sullivan, Margaret; Kanki, Phyllis J.
June 2004
Clinical Infectious Diseases;6/15/2004, Vol. 38 Issue 12, p1771
Academic Journal
Human immunodeficiency virus type 2 (HIV-2), the second human retrovirus known to cause AIDS, is endemic to West Africa but is infrequently found outside this region. We present a case series of 10 HIV-2-infected individuals treated in the United States. Physicians applied the principles of highly active antiretroviral therapy (HAART), normally used in treating HIV type 1, with modifications considered appropriate for treating HIV- 2. CD4+ cell count, HIV-2 virus load, and clinical status were found to correlate well, providing evidence that HIV-2 virus load is useful in managing treatment of patients with HIV-2 who are receiving therapy. However, HAART regimens with predicted efficacy for treatment of HIV type 1 infection are not as efficacious for treatment of HIV-2. Controlled clinical trials of HIV-2-infected patients receiving various HAART regimens are needed to provide therapeutic guidance to the medical community.


Related Articles

  • The burden of pediatric HIV/AIDS in Constanta, Romania: a cross-sectional study. Kozinetz, Claudia A.; Matusa, Rodica; Cazacu, Andreaa; Kozinetz, C A; Matusa, R; Cazacu, A // BMC Infectious Diseases;2001, Vol. 1 Issue 1, p7 

    Background: By 1990, 94 percent of the acquired immunodeficiency syndrome (AIDS) cases in Romania were in children less than 13 years of age. The majority of the cases were identified in the city of Constanta. The purpose of this paper was to describe the current burden of pediatric...

  • Mozambique issues compulsory license for HIV antiretrovirals.  // WHO Drug Information;2004, Vol. 18 Issue 2, p141 

    The HIV/AIDS pandemic constitutes a serious handicap in Mozambique's struggle against hunger, illness, underdevelopment and misery. High rates of morbidity and mortality have put Mozambique among the ten countries in Africa worst hit by HIV. Antiretroviral drugs are available which prolong the...

  • HIV�diagnosis and initial management. Rigg, Carolyn // InnovAiT;Sep2011, Vol. 4 Issue 9, p520 

    The global human immunodeficiency virus (HIV) epidemic continues, with 33.3 million people living with HIV and acquired immune deficiency syndrome (AIDS) worldwide (World Health Organization. Global summary of the HIV/AIDS epidemic (2009)). Twenty-two and a half million of those living with...

  • Paradoxical Effects of Clinician Emphasis on Adherence to Combination Antiretroviral Therapy for HIV/AIDS. Tugenberg, Toni; Ware, Norma C.; Wyatt, Monique A. // AIDS Patient Care & STDs;Apr2006, Vol. 20 Issue 4, p269 

    Constructive relationships between clinicians and patients being treated for HIV/AIDS are critical to treatment success. Trust, caring, and expertise have all been cited as important components of such relationships. As-yet unexamined, however, is the impact of the urgency patients sense in...

  • ORIGINAL ARTICLE Adherence Counseling Practices of Generalist and Specialist Physicians Caring for People Living with HIV/AIDS in North Carolina. Golin, Carol E.; Smith, Scott R.; Reif, Susan // JGIM: Journal of General Internal Medicine;Jan2004, Vol. 19 Issue 1, p16 

    National guidelines recommend that practitioners assess and reinforce patient adherence when prescribing antiretroviral (ART) medications, but the extent to which physicians do this routinely is unknown. To assess the adherence counseling practices of physicians caring for patients with HIV/AIDS...

  • Challenges of Improving Adherence to HIV Therapy. Thompson, Michael // American Family Physician;2/15/2011, Vol. 83 Issue 4, p375 

    The author discusses the need to improve adherence to human immunodeficiency virus (HIV) therapy. He relates that physicians are expected to design, implement and monitor antiretroviral regimens for effectiveness and potential complications, and cites factors that cause nonadherence to...

  • "Worrying" growth of drug resistant HIV is detected in China. Parry, Jane // BMJ: British Medical Journal (International Edition);10/25/2008, Vol. 337 Issue 7676, p952 

    The article reports that HIV resistance to drugs is increasing in China. A significant portion of treated patients are reported to have developed AIDS due to drug resistant mutations. The mutations are not unique to the people of China. The spread of infections beyond high risk groups and into...

  • Cellular Entry of HIV: Evaluation of Therapeutic Targets. Pohlmann, Stefan; Reeves, Jacqueline D // Current Pharmaceutical Design;Jun2006, Vol. 12 Issue 16, p1963 

    In the absence of a vaccine which could stop the HIV/AIDS pandemic, the development of therapeutic options is of utmost interest. The combined use of inhibitors of reverse transcriptase and protease as highly active antiretroviral therapy (HAART) provided the first effective treatment of...

  • HIV-1 Gene Therapy at Pre-Integration and Provirus DNA Levels. Nazari, Reza; Joshi, Sadhna // Current Gene Therapy;Feb2009, Vol. 9 Issue 1, p20 

    AIDS is the result of infection by a lentivirus, HIV-1, which primarily infects CD4+ T cells and macrophages. There is presently no vaccine and none will be available in the foreseeable future. Highly active antiretroviral drug therapy has led to a dramatic reduction of viral load in many...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics